Literature DB >> 30302616

Chick embryonic cells as a source for generating in vitro model of muscle cell dystrophy.

Verma Urja1, Kashmira Khaire1, Suresh Balakrishnan1, Gowri Kumari Uggini2.   

Abstract

Chick embryonic cells can be used to develop an easy and economical in vitro model for conducting studies on the disease muscle dystrophy (MD). For this, the limb myoblasts from 11th day chick embryo were isolated and cultured. To this muscle cell culture, anti-dystroglycan antibody (IIH6) was added so as to target the α-dystroglycan and disrupt the connection between the cytoskeletal proteins and the extracellular matrix (which is a characteristic feature of MD). Cells were allowed to differentiate further and the morphometrics and mRNA expression were studied. The IIH6-treated muscle cells displayed changes in morphometry, contractibility, and also atrophy was observed when compared to the control cultures. Concomitant gene expression studies showed an upregulation in TGF-β expression, while the muscle sculpture genes MYOD1, MYF5, LAMA2 and MYOG were downregulated resembling the MD in vivo. This simple and cost-effective method can be useful in studies to further understand the disease mechanism and also in conducting initial studies on effect of novel pharmacological agents.

Entities:  

Keywords:  Chick embryo; Embryonic cells; In vitro model; Muscle dystrophy; α-dystroglycan

Mesh:

Substances:

Year:  2018        PMID: 30302616     DOI: 10.1007/s11626-018-0297-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  36 in total

Review 1.  Building muscle: molecular regulation of myogenesis.

Authors:  C Florian Bentzinger; Yu Xin Wang; Michael A Rudnicki
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

3.  Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice.

Authors:  R A Williamson; M D Henry; K J Daniels; R F Hrstka; J C Lee; Y Sunada; O Ibraghimov-Beskrovnaya; K P Campbell
Journal:  Hum Mol Genet       Date:  1997-06       Impact factor: 6.150

Review 4.  Dystroglycan inside and out.

Authors:  M D Henry; K P Campbell
Journal:  Curr Opin Cell Biol       Date:  1999-10       Impact factor: 8.382

5.  Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.

Authors:  I Ziv; E Melamed; N Nardi; D Luria; A Achiron; D Offen; A Barzilai
Journal:  Neurosci Lett       Date:  1994-03-28       Impact factor: 3.046

6.  Immunochemical comparison of myosins from chicken cardiac, fast white, slow red, and smooth muscle.

Authors:  T Masaki
Journal:  J Biochem       Date:  1974-08       Impact factor: 3.387

Review 7.  Prevalence of muscular dystrophies: a systematic literature review.

Authors:  Alice Theadom; Miriam Rodrigues; Richard Roxburgh; Shiavnthi Balalla; Chris Higgins; Rohit Bhattacharjee; Kelly Jones; Rita Krishnamurthi; Valery Feigin
Journal:  Neuroepidemiology       Date:  2014-12-16       Impact factor: 3.282

8.  Mechanisms of muscle weakness in muscular dystrophy.

Authors:  Jeffery A Goldstein; Elizabeth M McNally
Journal:  J Gen Physiol       Date:  2010-07       Impact factor: 4.086

9.  Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products.

Authors:  T Braun; E Bober; G Buschhausen-Denker; S Kohtz; K H Grzeschik; H H Arnold; S Kotz
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

Review 10.  Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies.

Authors:  Sabrina Salani; Chiara Donadoni; Federica Rizzo; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.